- Home
- NERV vs RXST Comparison
NERV vs RXST Comparison
Compare NERV & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NERV | RXST |
|---|---|---|
| Founded | 2007 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.1M | 232.2M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NERV | RXST |
|---|---|---|
| Price | $4.56 | $6.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 10 |
| Target Price | ★ $10.50 | $9.78 |
| AVG Volume (30 Days) | 136.4K | ★ 973.3K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,175,600.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.93 | $4.48 |
| 52 Week High | $12.46 | $13.22 |
Technical Indicators
Market Signals| Indicator | NERV | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 52.73 | 68.48 |
| Support Level | $3.81 | $5.26 |
| Resistance Level | $4.61 | $7.60 |
| Average True Range (ATR) | 0.35 | 0.37 |
| MACD | 0.03 | 0.09 |
| Stochastic Oscillator | 65.79 | 84.08 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.